Attached files

file filename
EX-31.1 - CERTIFICATION - ACRO BIOMEDICAL CO., LTD.acbm_ex311.htm
EX-10.2 - PURCHASE CONTRACT - ACRO BIOMEDICAL CO., LTD.acbm_ex102.htm
EX-10.1 - PURCHASE CONTRACT - ACRO BIOMEDICAL CO., LTD.acbm_ex101.htm
10-K/A - FORM 10-K/A - ACRO BIOMEDICAL CO., LTD.acbm_10ka.htm

EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO

 

18 U.S.C. SECTION 1350,

 

AS ADOPTED PURSUANT TO

 

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of Acro Biomedical Co., Ltd. (the “Company”) on Form 10-K/A for the year ended September 30, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Pao-Chi Chu, chief executive officer of the Company, and acting chief financial officer of the Company, certify, pursuant to 18 U.S.C. section 1350 of the Sarbanes-Oxley Act of 2002, that:

 

 

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

 

 

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

       

Date: January16, 2018

By: /s/ Pao-Chi Chu

 

 

Pao-Chi Chu

 
   

Chief Executive Officer and Chief

Financial Officer

 
   

(Principal Executive, Financial and

Accounting Officer)